Publication | Closed Access

Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions

MedicineHistone Deacetylase InhibitorsImmunologyImmune Checkpoint InhibitorCytolytic Effector FunctionsAnti-cancer AgentTumor SuppressorImmunotherapyOncologyCell BiologyTumor MicroenvironmentCancer ResearchTumour-reactive Nk Cells